Product Details

Teva-Sertraline

Sertraline HCl
100 mg
Capsule


DIN/PIN/NPN

02240481

Manufacturer

Teva Canada Limited

Formulary Listing Date

2000-01-17  

Unit Price

0.3303

Amount MOH Pays

0.3303

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Sertraline HCl: Sertraline therapy should be discontinued for 2 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting sertraline.

ATC Code

N06AB06

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
01962779 Zoloft 2.1464 0.3303
02240481 Teva-Sertraline 0.3303 0.3303
02469642 Sertraline 0.3303 0.3303
02386097 Sertraline 0.3303 0.3303
02353547 Sertraline 0.3303 0.3303
02245161 Sandoz Sertraline 0.3303 0.3303
02374579 Ran-Sertraline 0.3303 0.3303
02244840 PMS-Sertraline 0.3303 0.3303
02488450 NRA-Sertraline 0.3303 0.3303
02402408 Mint-Sertraline 0.3303 0.3303
02399431 Mar-Sertraline 0.3303 0.3303
02357178 Jamp-Sertraline 0.3303 0.3303
02287412 Co Sertraline 0.3303 0.3303
02390922 Auro-Sertraline 0.3303 0.3303
02238282 Apo-Sertraline 0.3303 0.3303
02477904 AG-Sertraline 0.3303 0.3303
02530953 M-Sertraline 0.3303 0.3303
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph